tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market

Glenmark Pharmaceuticals Limited (GLENMARK) Income Statement

Compare
0 Followers

Glenmark Pharmaceuticals Limited Income Statement

Last quarter (Q1 2024), Glenmark Pharmaceuticals Limited's total revenue was ₹32.44B, a decrease of -2.76% from the same quarter last year. In Q1, Glenmark Pharmaceuticals Limited's net income was ₹3.40B. See Glenmark Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 131.46B₹ 118.13B₹ 115.83B₹ 121.74B₹ 108.06B
Gross Profit
₹ 54.60B₹ 32.59B₹ 36.30B₹ 41.09B₹ 35.80B
Operating Expenses
₹ 35.95B₹ 46.95B₹ 25.29B₹ 23.57B₹ 19.67B
Depreciation and Amortization
₹ 4.86B₹ 5.82B₹ 6.11B₹ 4.87B₹ 4.44B
EBITDA
₹ 20.92B₹ 11.34B₹ 11.58B₹ 22.26B₹ 21.79B
Operating Income
₹ 18.65B₹ 6.31B₹ 10.79B₹ 18.40B₹ 17.16B
Other Income/Expenses
₹ -4.66B₹ -5.95B₹ -8.39B₹ -3.99B₹ -3.34B
Pretax Income
₹ 13.99B₹ 364.95M₹ 2.40B₹ 14.41B₹ 13.82B
Net Income
₹ 10.47B₹ -15.02B₹ 2.97B₹ 9.42B₹ 9.70B
Per Share Metrics
Basic EPS
₹ 37.11₹ -53.22₹ 10.53₹ 33.37₹ 34.38
Diluted EPS
₹ 37.11₹ -53.22₹ 10.53₹ 33.37₹ 34.38
Weighted Average Shares Outstanding
282.16M 282.16M 282.17M 282.17M 282.17M
Weighted Average Shares Outstanding (Diluted)
282.16M 282.18M 282.17M 282.17M 282.17M
Currency in INR

Glenmark Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis